Cargando…
The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study
Enzymatic replacement therapy (ERT) is not very effective in halting the progression of Fabry disease (FD) toward cardiovascular (CV)-renal remodeling, particularly in case of late diagnosis. FD patients have increased oxidative stress (OS), critical for the induction of CV-renal remodeling. We inve...
Autores principales: | Bertoldi, Giovanni, Carraro, Gianni, Ravarotto, Verdiana, Di Vico, Valentina, Baldini Anastasio, Paola, Vitturi, Nicola, Francini, Francesco, Stefanelli, Lucia Federica, Calò, Lorenzo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304972/ https://www.ncbi.nlm.nih.gov/pubmed/35873439 http://dx.doi.org/10.3389/fnut.2022.924710 |
Ejemplares similares
-
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
por: Ravarotto, Verdiana, et al.
Publicado: (2018) -
Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach
por: Rigato, Matteo, et al.
Publicado: (2022) -
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
por: Ravarotto, Verdiana, et al.
Publicado: (2018) -
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
por: Bertoldi, Giovanni, et al.
Publicado: (2023) -
Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More
por: Ravarotto, Verdiana, et al.
Publicado: (2022)